Document is current

Any future updates will be listed below

NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy

Crossref DOI link: https://doi.org/10.1038/srep45540

Published Online: 2017-03-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark